Frontlight ResearchEarly access
Trial site
Yeungnam Univeristy Medical Center
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Asthma1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Status
- Completed3 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- Pfizer1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
Closed trials
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026